| scholarly article | Q13442814 |
| P50 | author | Mark H. Tuszynski | Q21856455 |
| Michael J Castle | Q57021514 | ||
| Aravind Asokan | Q91787026 | ||
| P2093 | author name string | Yuhsiang Cheng | |
| P2860 | cites work | Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial | Q28296434 |
| Sleep drives metabolite clearance from the adult brain | Q29620065 | ||
| Immunochemical characterization of inhibitory mouse cortical neurons: three chemically distinct classes of inhibitory cells | Q33584088 | ||
| Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease | Q33726762 | ||
| Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse | Q33732656 | ||
| Differential adeno-associated virus mediated gene transfer to sensory neurons following intrathecal delivery by direct lumbar puncture | Q33975660 | ||
| Intracranial injection of AAV expressing NEP but not IDE reduces amyloid pathology in APP+PS1 transgenic mice | Q34651703 | ||
| Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates | Q35086714 | ||
| Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates | Q35153080 | ||
| Gene therapy for pain: results of a phase I clinical trial | Q35154100 | ||
| The pyramidal neuron of the cerebral cortex: morphological and chemical characteristics of the synaptic inputs | Q35420341 | ||
| Stereological estimates of the basal forebrain cell population in the rat, including neurons containing choline acetyltransferase, glutamic acid decarboxylase or phosphate-activated glutaminase and colocalizing vesicular glutamate transporters | Q35697190 | ||
| Differential expression of CaMKII isoforms and overall kinase activity in rat dorsal root ganglia after injury | Q35798313 | ||
| Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates | Q35892068 | ||
| Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates | Q36745664 | ||
| Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primates | Q36848703 | ||
| Early BDNF treatment ameliorates cell loss in the entorhinal cortex of APP transgenic mice | Q37196325 | ||
| Glymphatic fluid transport controls paravascular clearance of AAV vectors from the brain | Q37277317 | ||
| Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain | Q37382030 | ||
| Intracisternal delivery of AAV9 results in oligodendrocyte and motor neuron transduction in the whole central nervous system of cats | Q39415889 | ||
| Evaluation of intrathecal routes of administration for adeno-associated virus vectors in large animals. | Q40083638 | ||
| Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems | Q40137101 | ||
| Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders | Q40235080 | ||
| Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer's disease mouse models. | Q40693796 | ||
| Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease | Q40846012 | ||
| Transduction Profile of the Marmoset Central Nervous System Using Adeno-Associated Virus Serotype 9 Vectors. | Q40906363 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes | Q42739394 | ||
| Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain | Q44686125 | ||
| Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain. | Q45324243 | ||
| Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC. | Q45859568 | ||
| Efficient central nervous system AAVrh10-mediated intrathecal gene transfer in adult and neonate rats | Q45872026 | ||
| Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy | Q45873849 | ||
| A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease | Q45883058 | ||
| Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP-treated monkeys | Q48325968 | ||
| Arterial vascularisation of the anterior perforated substance. | Q49086405 | ||
| The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice. | Q50083826 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | eaau9859 | |
| P577 | publication date | 2018-11-14 | |
| P1433 | published in | Science Advances | Q19881044 |
| P1476 | title | Physical positioning markedly enhances brain transduction after intrathecal AAV9 infusion | |
| P478 | volume | 4 |
| Q92666846 | AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice |
| Q90002291 | Postmortem Analysis in a Clinical Trial of AAV2-NGF Gene Therapy for Alzheimer's Disease Identifies a Need for Improved Vector Delivery |
| Q64245388 | The Application of Adeno-Associated Viral Vector Gene Therapy to the Treatment of Fragile X Syndrome |
Search more.